Pages that link to "Q42609151"

The following pages link to The 25-hydroxyvitamin D threshold for better health (Q42609151):

Displaying 31 items.

• Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country (Q21257203) (← links)
• Vitamin D and the skin: Focus on a complex relationship: A review (Q26773618) (← links)
• Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial (Q33567637) (← links)
• Effect of vitamin D supplementation on bone health parameters of healthy young Indian women (Q33720218) (← links)
• The association of serum 25-hydroxyvitamin D with indicators of bone quality in men of Caucasian and African ancestry. (Q33754970) (← links)
• Vitamin D supplementation to prevent falls in the elderly: evidence and practical considerations (Q33845432) (← links)
• Vitamin D and depression: where is all the sunshine? (Q34012636) (← links)
• Vitamin D supplementation: what's known, what to do, and what's needed. (Q34264605) (← links)
• Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board. (Q34307388) (← links)
• Vitamin D is a major determinant of bone mineral density at school age. (Q34329077) (← links)
• Hypovitaminosis D in obese and overweight schoolchildren (Q34423022) (← links)
• Mitigating epidemic vitamin D deficiency: the agony of evidence (Q34506209) (← links)
• Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. (Q35062574) (← links)
• Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women (Q35524921) (← links)
• Vitamin D Receptor Expression in Vitiligo (Q36376862) (← links)
• Calciotropic hormones and the risk of hip and nonspine fractures in older adults: the Health ABC Study (Q36523333) (← links)
• Serum 25-hydroxyvitamin D concentrations and risk for hip fractures (Q37345469) (← links)
• Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D₃. (Q37359637) (← links)
• Nutritional supplements for older adults: review and recommendations-part I. (Q37398756) (← links)
• Brigham fracture intervention team initiatives for hospital patients with hip fractures: a paradigm shift (Q37423219) (← links)
• Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women (Q37441945) (← links)
• Use of calcium, folate, and vitamin D₃-fortified milk for 6 months improves nutritional status but not bone mass or turnover, in a group of Australian aged care residents (Q42772205) (← links)
• Factors associated with recall of media reports about vitamin D and sun protection (Q44073032) (← links)
• The response of elderly veterans to daily vitamin D3 supplementation of 2,000 IU: a pilot efficacy study (Q45330787) (← links)
• Vitamin D supplement consumption is required to achieve a minimal target 25-hydroxyvitamin D concentration of > or = 75 nmol/L in older people (Q46443443) (← links)
• High prevalence of hypovitaminosis D and secondary hyperparathyroidism in elders living in nonprofit homes in South Brazil (Q46653231) (← links)
• (Q55464142) (← links)
• Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality (Q57391136) (← links)
• Vitamin D and its Relation to Bone Mineral Density in Postmenopause Women. (Q64968871) (← links)
• Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy (Q80689018) (← links)
• Decreased neuromuscular function in Crohn's disease patients is not associated with low serum vitamin D levels (Q95404239) (← links)